NCT00182650View on ClinicalTrials.gov

Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Lymphoma
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

rituximab

BIOLOGICAL

therapeutic autologous lymphocytes

DRUG

fludarabine phosphate

Trial Locations (1)

91010-3000

City of Hope Comprehensive Cancer Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00182650 - Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter